Secret Survey Roots Out Korean Firms Offering Rebates
This article was originally published in PharmAsia News
Executive Summary
In an unprecedented move to eliminate rebates in the pharma industry, South Korean pharma firms have conducted an anonymous survey to identify firms suspected of being involved in the practice in return for prescriptions.
You may also be interested in...
Novartis Korea May Face Business Suspension In Rebate Probe
Novartis’ South Korean subsidiary could face a business suspension and other administrative measures after prosecutors indicted several employees without detention on charges of illegal rebate payments.
AI Healthcare, Medical Devices Shine In Korea Q1 Financings
After the financing draught suffered by Korean bioventures in 2023, it now seems the VC market is poised for a recovery as investors shift attention again to the healthcare sector, with a spotlight on AI-based solutions and device firms.
Window Of Opportunity: Korea Unveils Cutting-Edge Bio Initiative
South Korea is moving forward with plan to set up a Boston-type biotech cluster in Osong as part of a broader initiative unveiled by President Yoon, while the biopharma industry is calling for rapid process, exceptional support.